INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Early Oncology Clinical Trials: Key Considerations To Plan For Success
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
-
Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic
How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.
-
Streamlining Patient Recruitment With AI–Driven Site Identification
This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.
-
Advancing Oncology Innovation With Adaptive Trial Designs
When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success10/15/2025
The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.
-
Working With A Specialty Oncology CRO Versus A Large Generalist CRO10/2/2025
Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.
-
How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era8/8/2025
As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.
-
Decisions In Cell And Gene Therapy Development7/2/2024
Explore critical decisions across clinical trial design, patient recruitment, site selection, logistics, manufacturing, and long-term follow-up, aiming to guide stakeholders through CAGT development.
-
Building Bioanalysis Infrastructure For Modern Drug Development10/20/2025
Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Whether you need a few scientific experts or a fully-staffed function, gain flexibility and results with Veristat’s Strategic Resourcing Solution and confidently meet your study milestones.
-
Partnering with TFS offers flexible, scalable sourcing solutions for clinical development, supporting trials from early discovery through post-market, regardless of therapeutic area.
-
Streamline workflows across all types of sites, including academic medical centers and commercial sites of varying sizes, with Advarra’s complete suite of independent oversight committees.
-
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.